Standard Biotools (LAB) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.12% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | -2.38% |
| Jun 30, 2025 | 22.60% |
| Mar 31, 2025 | 23.57% |
| Dec 31, 2024 | -2.13% |
| Sep 30, 2024 | 20.59% |
| Jun 30, 2024 | 9.71% |
| Mar 31, 2024 | 9.31% |
| Dec 31, 2023 | 7.03% |
| Sep 30, 2023 | 6.61% |
| Jun 30, 2023 | 12.13% |
| Mar 31, 2023 | 9.19% |
| Dec 31, 2022 | 0.75% |
| Sep 30, 2022 | 4.26% |
| Jun 30, 2022 | -7.17% |
| Mar 31, 2022 | -10.91% |
| Sep 30, 2021 | 23.34% |
| Jun 30, 2021 | 18.51% |
| Mar 31, 2021 | 18.38% |
| Dec 31, 2020 | 11.81% |
| Sep 30, 2020 | 24.21% |
| Jun 30, 2020 | 19.43% |
| Mar 31, 2020 | 16.30% |
| Dec 31, 2019 | 14.33% |
| Sep 30, 2019 | 17.26% |
| Jun 30, 2019 | 14.97% |
| Mar 31, 2019 | 5.05% |
| Dec 31, 2018 | -14.87% |
| Sep 30, 2018 | -17.45% |
| Jun 30, 2018 | -21.29% |
| Mar 31, 2018 | -19.42% |
| Dec 31, 2017 | -14.04% |
| Sep 30, 2017 | -20.64% |
| Jun 30, 2017 | -21.40% |
| Mar 31, 2017 | -12.32% |
| Dec 31, 2016 | -29.11% |
| Sep 30, 2016 | -25.32% |
| Jun 30, 2016 | -12.20% |
| Mar 31, 2016 | 15.48% |
| Dec 31, 2015 | 22.11% |
| Sep 30, 2015 | 29.05% |
| Jun 30, 2015 | 27.19% |